Purchases and Sales Made in Q3 2023 in Denali Therapeutics Inc. (DNLI)
This table provides information about the institutional ownership of Denali Therapeutics Inc. (DNLI) during Q3 2023. The information is specifically focused on institutions that hold shares of Denali Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2023
Q3 2023
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-19.2K- 7.73% |
$396K - $580K
|
229K
$3.38M
|
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
SELL
|
- |
-22.2K- 16.86% |
$459K - $671K
|
110K
$1.62M
|
|
|
Nov 14, 2023
Q3 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-23.8K- 20.23% |
$491K - $718K
|
93.8K
$1.38M
|
|
|
Nov 13, 2023
Q3 2023
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-24.6K- 36.73% |
$507K - $742K
|
42.3K
$625K
|
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-26.6K- 16.38% |
$549K - $803K
|
136K
$2.01M
|
|
|
Nov 09, 2023
Q3 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-28.4K- 19.59% |
$585K - $856K
|
116K
$1.72M
|
|
|
Nov 14, 2023
Q3 2023
|
International Biotechnology Trust PLC
London, X0 |
SELL
|
- |
-34K- 18.09% |
$701K - $1.03M
|
154K
$2.27M
|
|
|
Nov 14, 2023
Q3 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-34.1K- 46.79% |
$703K - $1.03M
|
38.7K
$572K
|
|
|
Nov 14, 2023
Q3 2023
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-42K- 23.48% |
$866K - $1.27M
|
137K
$2.02M
|
|
|
Oct 21, 2024
Q3 2023
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-73.6K- 78.81% |
$1.52M - $2.22M
|
19.8K
$292K
|
|
|
Nov 14, 2023
Q3 2023
|
Man Group PLC
London, X0 |
SELL
|
- |
-81.6K- 16.15% |
$1.68M - $2.46M
|
424K
$6.25M
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-95.3K- 8.85% |
$1.97M - $2.88M
|
982K
$14.5M
|
|
|
Nov 14, 2023
Q3 2023
|
Crestline Management, LP
Fort Worth, TX |
SELL
|
- |
-150K- 2.45% |
$3.09M - $4.53M
|
5.96M
$88M
|
|
|
Nov 13, 2023
Q3 2023
|
Baillie Gifford & CO
|
SELL
|
- |
-163K- 1.1% |
$3.36M - $4.91M
|
14.7M
$217M
|
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-193K- 4.32% |
$3.98M - $5.83M
|
4.28M
$63.1M
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-238K- 36.83% |
$4.9M - $7.17M
|
407K
$6.01M
|
|
|
Nov 14, 2023
Q3 2023
|
Gilder Gagnon Howe & CO LLC
New York, NY |
SELL
|
- |
-334K- 21.12% |
$6.89M - $10.1M
|
1.25M
$18.4M
|
|
|
Nov 14, 2023
Q3 2023
|
Wasatch Advisors Inc
Salt Lake City, UT |
SELL
|
- |
-511K- 61.38% |
$10.5M - $15.4M
|
321K
$4.74M
|
|
|
Nov 14, 2023
Q3 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-553K- 16.06% |
$11.4M - $16.7M
|
2.89M
$42.7M
|
|
|
Nov 13, 2023
Q3 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-943KClosed |
$19.5M - $28.5M
|
0
$0
|